Go Pro
TSE:IMV

IMV (IMV) Stock Price, News & Analysis

IMV logo

About IMV Stock (TSE:IMV)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
15,761 shs
Average Volume
56,822 shs
Market Capitalization
C$13.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Receive IMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMV and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMV Stock News Headlines

IMV Inc. Common Shares (IMV)
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
Why did EDSA stock rally more than 70% today?
See More Headlines

IMV Stock Analysis - Frequently Asked Questions

IMV's stock reverse split on Monday, December 12th 2022.The 1-10 reverse split was announced on Monday, December 12th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of IMV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that IMV investors own include Aurora Cannabis (ACB), 10094 (IRD.TO) (IRD), Manulife Financial (MFC), Village Farms International (VFF), Bombardier, Inc. Class B (BBD.B), Cronos Group (MJN) and Enbridge (ENB).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
TSE:IMV
CIK
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($6.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$37.99 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-508.58%
Return on Assets
-61.78%

Debt

Debt-to-Equity Ratio
1,231.01
Current Ratio
2.93
Quick Ratio
2.32

Sales & Book Value

Annual Sales
C$23 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
1.61
Book Value
C($0.69) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
11,710,000
Free Float
N/A
Market Cap
C$13.12 million
Optionable
Not Optionable
Beta
1.52
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (TSE:IMV) was last updated on 8/11/2026 by MarketBeat.com Staff.
From Our Partners